PURPOSECannabis has been legalized across multiple states over the past decade; however, its use among cancer survivors ...

Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is often limited by ...